New therapy with XLQ® to suppress chronic prostatitis through its anti-inflammatory and antioxidative activities

Journal of Cellular Physiology
Feiya YangNianzeng Xing

Abstract

Chronic prostatitis is a common urological disease. The etiology of this disease and effective therapy for its treatment are yet to be elucidated. We investigated the functions of XLQ® in chronic nonbacterial prostatitis using a complete Freund's adjuvant-induced rat model. Prostates and blood samples were collected for further evaluation after oral gavage with XLQ ® or a vehicle for 4 weeks. The results showed that XLQ ® significantly decreased the prostate index, ameliorated the histopathologic changes, and reduced CD3+ and CD45+ cell infiltration in the prostate stroma. Further study showed that XLQ ® suppressed the expression of proinflammatory cytokines, such as interleukin (IL)-1β, IL-2, IL-6, IL-17A, monocyte chemoattractant protein-1, and tumor necrosis factor-α. XLQ ® showed a strong antioxidant capacity by enhancing the activities of antioxidative enzymes (e.g., total superoxide dismutase, catalase, and glutathione peroxidase) and decreasing the level of lipid peroxidation products (malondialdehyde). Moreover, XLQ ® can suppress the activation of nuclear factor-κB and P38-mitogen-activated protein kinase signaling pathways. In summary, XLQ ® has affirmative effects on chronic prostatitis, which could be attributed to ...Continue Reading

References

Aug 13, 2003·The Journal of Urology·J Curtis NickelUNKNOWN Chronic Prostatitis Collaborative Research Network Study Group
Aug 18, 2004·The Journal of Urology·Michel A Pontari, Michael R Ruggieri
Jan 18, 2006·Annual Review of Medicine·Geoffrey M HabermacherAnthony J Schaeffer
Oct 20, 2006·The New England Journal of Medicine·Anthony J Schaeffer
Jan 3, 2007·Prostate Cancer and Prostatic Diseases·E V VykhovanetsS Gupta
Jul 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Giuseppe PennaLuciano Adorini
Oct 26, 2011·The Prostate·Tiiu KullisaarReet Mändar
Jul 21, 2012·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Marsha L QuickPraveen Thumbikat
Aug 26, 2014·Autoimmunity Reviews·Ram Pyare SinghAwlad Hossain
May 2, 2015·PloS One·Stephen F MurphyPraveen Thumbikat
Mar 10, 2016·Prostate Cancer and Prostatic Diseases·A S Polackwich, D A Shoskes
Apr 27, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Li LinLiang Cai
Aug 18, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Farhan Ullah KhanXiaohui Zhou
Feb 24, 2018·International Immunopharmacology·Laise Aline Martins Dos SantosChristina Alves Peixoto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.